Why Anushka Sen is debuting in Korea
Learn everything about her trip to Korea and how this 19-year-old Bollywood actor and influencer is shaking up the industry with her passion for connecting Asia through content.
The Korea Herald
Samsung starts mass production of world’s first 3-nm chips
The latest 3-nanometer manufacturing technology boasts greater transistor density than the current 5-nm, which means higher speed and lower power consumption.
Worsening inflation outlook fuels sharper rate hike bets for South Korea
The monthly increase observed in the survey is also the largest gain seen since the Bank of Korea began compiling data in 2008.
Korea approves 1st homegrown Covid-19 vaccine
The government on June 29 announced the approval of SKYCovione, which has been authorised for two administrations with a four-week interval on people aged 18 or older.
Korea, US, Japan discuss trilateral security cooperation
The trilateral talk was the first in four years and nine months since the last held on the occasion of the UN General Assembly in September 2017.
North Korea denounces US, key allies for seeking to build ‘Asian Nato’
North Korea also criticized the US initiative to forge strong security links between its allies in the North Atlantic and Asia-Pacific areas.
Is Yoon’s team hinting at wider strategy veering away from China?
Maintaining good relations with China may be difficult, experts say.
North Korean leader discusses tightening party control, reorganizing party departments
Experts shared the view that an implication of the meeting was that North Korean officials reviewed ways to reinforce party control over the organs surveilling and regulating…
North Korea denounces Japan, US over ‘false’ charges of Japanese abductions
North Korea claims that it had repatriated five of 13 Japanese nationals and the remaining had died. But Japan disagrees with their claim.
South Korea close to authorizing 1st homemade vaccine
Those aged 18 or older, who received two doses of SKYCovione vaccine with a 4-week interval, had 2.93 times more neutralizing antibodies than a control group.